Shalby Q3 FY26: Standalone PAT falls, board okays rights issue in PK Healthcare
SHALBY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.3 pts less than Nifty Microcap 250 and 7.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Shalby Q3 FY26: Standalone revenue Rs 2,152.36M (vs Rs 2,206.40M YoY), PAT Rs 137.91M (vs Rs 208.58M YoY). Consolidated PAT was just Rs 12.78M vs loss of Rs 29.93M YoY. 9M FY26 standalone PAT fell to Rs 592.42M from Rs 688.35M. Board approved re-appointment of Independent Director Shyamal Joshi for 5 more years, rights issue of Rs 59.60 crore in subsidiary PK Healthcare, and strike-off of inactive step-down unit Ningen Lifecare.
Mixed results: standalone PAT declined sharply YoY, but consolidated returned to profit. Subsidiary restructuring underway.